Profitelligence Profitelligence · Filing Ledger Open ABT research →

Form 8-K · Current Report · Filed 2025-04-28

Abbott Laboratories Announces Annual Meeting Results

Abbott Laboratories held its Annual Meeting of Shareholders on April 25, 2025.

Filer
Abbott Laboratories ABT · NYSE
Filed
Accession
0001104659-25-040201
CIK
0000001800
Signal
Low impactHealthcare

Details

Shareholders elected the entire Board of Directors, ratified the appointment of Ernst & Young LLP as auditors, and approved the compensation of named executive officers. The election results show overwhelming support for the Board, with the majority of votes cast in favor of each director. The ratification of auditors and approval of executive compensation also received significant support.

Items reported

Item 5.07

Submission of Matters to a Vote of Security Holders

Director Elections Results Say-on-Pay Approved

Market reaction

Close before filing

$128.85

Next session

+1.3%

Since filing

-18.0%

Latest close

$105.70

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from ABT reporting the same item, with the next session's move:

About Abbott Laboratories

Abbott Laboratories, a globally renowned company, specializes in the development and production of healthcare and medical products. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a pivotal entity in the healthcare sector. The company provides essential products spanning diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. Notably, Abbott's extensive diagnostic solutions include immunoassays and molecular diagnostics, crucial for medical testing and healthcare management. Its medical devices division produces cardiovascular and neuromodulation products, enhancing patient care across diverse medical practices. Abbott’s nutritional segment, featuring well-known brands like Similac and Ensure, supports health and wellness across various demographics. Serving markets globally, Abbott Laboratories plays a critical role in advancing healthcare infrastructure and delivering innovative solutions that address evolving health challenges worldwide. As a significant player in the life sciences field, Abbott's contributions significantly influence patient outcomes and healthcare delivery systems.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another ABT filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts